Allergan (AGN) (21% premium) • Novartis/GSK major 3-part transaction, exchange certain assets, form consumer-health venture • Novartis to divest Animal Health to Lilly for $5.4B (NOVN VX +2.3%, GSK LN +5.3%, LLY no volume) • Astrazeneca ADR's closed +8.8% yesterday on Sunday Times story of Pfizer talks (trading +6